- Home
- RGEN vs CIGI Comparison
RGEN vs CIGI Comparison
Compare RGEN & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- CIGI
- Stock Information
- Founded
- RGEN 1981
- CIGI 1972
- Country
- RGEN United States
- CIGI Canada
- Employees
- RGEN N/A
- CIGI N/A
- Industry
- RGEN Medical/Dental Instruments
- CIGI
- Sector
- RGEN Health Care
- CIGI
- Exchange
- RGEN Nasdaq
- CIGI Nasdaq
- Market Cap
- RGEN 9.1B
- CIGI 7.4B
- IPO Year
- RGEN N/A
- CIGI N/A
- Fundamental
- Price
- RGEN $158.99
- CIGI $125.50
- Analyst Decision
- RGEN Buy
- CIGI Buy
- Analyst Count
- RGEN 11
- CIGI 6
- Target Price
- RGEN $180.63
- CIGI $165.50
- AVG Volume (30 Days)
- RGEN 652.6K
- CIGI 147.6K
- Earning Date
- RGEN 02-20-2025
- CIGI 02-06-2025
- Dividend Yield
- RGEN N/A
- CIGI 0.24%
- EPS Growth
- RGEN N/A
- CIGI 127.75
- EPS
- RGEN N/A
- CIGI 3.22
- Revenue
- RGEN $634,439,000.00
- CIGI $4,822,024,000.00
- Revenue This Year
- RGEN $2.28
- CIGI $12.21
- Revenue Next Year
- RGEN $9.69
- CIGI $5.51
- P/E Ratio
- RGEN N/A
- CIGI $39.32
- Revenue Growth
- RGEN 0.33
- CIGI 11.23
- 52 Week Low
- RGEN $113.50
- CIGI $101.01
- 52 Week High
- RGEN $203.13
- CIGI $156.96
- Technical
- Relative Strength Index (RSI)
- RGEN 53.41
- CIGI 32.48
- Support Level
- RGEN $143.83
- CIGI $129.79
- Resistance Level
- RGEN $169.00
- CIGI $132.32
- Average True Range (ATR)
- RGEN 5.95
- CIGI 4.22
- MACD
- RGEN -0.24
- CIGI -1.15
- Stochastic Oscillator
- RGEN 61.46
- CIGI 6.30
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc is a real estate services and investment management company. The company provides commercial real estate professional services and investment management to corporate and institutional clients around the world. It's primary service lines are Outsourcing & Advisory, Investment Management, Leasing and Capital Markets. Operationally, company is organized into four distinct segments: Americas; Europe, Middle East and Africa, Asia and Australasia and Investment Management.